Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Evaluating head positioning after retinal detachment repair

Official title: Head Positioning Duration After Retinal Detachment Repair With Vitrectomy and Gas

Run by University of Kansas Medical Center · NCT03714503 · Data updated 2026-11-12

This study is testing if lying face down for just one day after retinal detachment surgery works as well as lying face down for seven days for patients with certain types of retinal breaks.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity of Kansas Medical Center
Academic / other
Locations1 site (Prairie Village, Kansas)
StatusRecruiting
StartedApril 8, 2019
Main results expectedDecember 2028
Study endsDecember 2028
Registry record updatedMay 5, 2026
Trial IDNCT03714503 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older diagnosed with primary rhegmatogenous retinal detachment with inferior breaks.

Probably not a fit

Patients who may not benefit include those with a history of previous retinal detachment repair in the study eye or those with other specific retinal conditions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates whether one day of prone head positioning after surgery for retinal detachment is as effective as seven days of the same positioning. It focuses on patients with inferior retinal breaks who have undergone pars plana vitrectomy using C3F8 gas as a tamponade. The study employs a single-arm phase II design with a Simon's two-stage approach to assess the anatomical success of the retina at three months and one year post-operatively. A total of 20 patients will be recruited, with the first stage determining if the trial should continue based on initial success rates.

Why it matters

Potential benefit: If successful, this study could reduce the duration of required prone positioning after retinal detachment surgery, improving patient comfort and compliance.

How similar studies have gone: While similar studies have explored post-operative positioning, this specific approach is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ability to understand and the willingness to sign a written informed consent
* Subjects must be diagnosed with primary rhegmatogenous retinal detachment with inferior breaks
* Subjects must be 18 years and older.
* Women of child-bearing potential must agree to take rapid urine pregnancy test before surgical procedure and have negative result.

Exclusion Criteria:

* pediatric population
* pregnant women
* a previous retinal detachment repair in the study eye
* history of scleral buckling in the study eye
* trauma as a cause of the retinal detachment
* asymptomatic longstanding retinal detachments
* non-compliance with post-operative treatment
* phakic retinal detachment
* exudative retinal detachment
* retinoschisis related retinal detachment

Where it's running

  • University of Kansas Medical Center
    Prairie Village, Kansas, United States
    Recruiting

Study contacts

  • Principal investigator: Radwan Ajlan, MD — University of Kansas Medical Center
  • Study coordinator: Ariana Madrigal
  • Email: amadrigal2@kumc.edu
  • Phone: 9135880105

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.